Public health impact and cost-effectiveness of 20-valent pneumococcal conjugate vaccine use among children in the United States.

Saved in:
Bibliographic Details
Title: Public health impact and cost-effectiveness of 20-valent pneumococcal conjugate vaccine use among children in the United States.
Authors: Ayabina D; Division of Bacterial Diseases, National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, United States; Prevention Effectiveness Fellowship, Centers for Disease Control and Prevention, United States. Electronic address: dayabina@ihe.ca., Stoecker C; Department of Health Policy and Management, School of Public Health and Tropical Medicine, Tulane University, United States., Cho BH; School of Public Health, University of California, Berkeley, United States., Prasad N; Division of Bacterial Diseases, National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, United States., King LM; School of Public Health, University of California, Berkeley, United States., Leidner AJ; Immunization Services Division, National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, United States., Kobayashi M; Division of Bacterial Diseases, National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, United States.
Source: Vaccine [Vaccine] 2026 Feb 27; Vol. 74, pp. 128212. Date of Electronic Publication: 2026 Jan 20.
Publication Type: Journal Article
Journal Info: Publisher: Elsevier Science Country of Publication: Netherlands NLM ID: 8406899 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1873-2518 (Electronic) Linking ISSN: 0264410X NLM ISO Abbreviation: Vaccine Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:1873-2518
DOI:10.1016/j.vaccine.2026.128212